- Home
- QGEN vs EHC Comparison
QGEN vs EHC Comparison
Compare QGEN & EHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- EHC
- Stock Information
- Founded
- QGEN 1986
- EHC 1983
- Country
- QGEN Netherlands
- EHC United States
- Employees
- QGEN N/A
- EHC N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- EHC Hospital/Nursing Management
- Sector
- QGEN Health Care
- EHC Health Care
- Exchange
- QGEN Nasdaq
- EHC Nasdaq
- Market Cap
- QGEN 10.3B
- EHC 12.3B
- IPO Year
- QGEN 1996
- EHC 1986
- Fundamental
- Price
- QGEN $45.84
- EHC $124.42
- Analyst Decision
- QGEN Buy
- EHC Strong Buy
- Analyst Count
- QGEN 8
- EHC 7
- Target Price
- QGEN $51.01
- EHC $139.29
- AVG Volume (30 Days)
- QGEN 1.3M
- EHC 629.1K
- Earning Date
- QGEN 11-05-2025
- EHC 10-27-2025
- Dividend Yield
- QGEN 3.32%
- EHC 0.61%
- EPS Growth
- QGEN 405.09
- EHC 30.39
- EPS
- QGEN 1.69
- EHC 5.11
- Revenue
- QGEN $2,040,067,000.00
- EHC $5,669,100,000.00
- Revenue This Year
- QGEN $7.22
- EHC $11.57
- Revenue Next Year
- QGEN $5.66
- EHC $8.79
- P/E Ratio
- QGEN $26.93
- EHC $24.31
- Revenue Growth
- QGEN 5.15
- EHC 11.80
- 52 Week Low
- QGEN $37.63
- EHC $87.85
- 52 Week High
- QGEN $51.88
- EHC $127.15
- Technical
- Relative Strength Index (RSI)
- QGEN 39.86
- EHC 57.57
- Support Level
- QGEN $45.18
- EHC $123.39
- Resistance Level
- QGEN $46.18
- EHC $127.15
- Average True Range (ATR)
- QGEN 0.67
- EHC 1.94
- MACD
- QGEN -0.12
- EHC -0.39
- Stochastic Oscillator
- QGEN 26.69
- EHC 53.01
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.